Compliance with osteoporosis therapy is the weakest link

被引：61

作者：

Compston, Juliet E. ^{[1
]}

Seeman, Ego

机构：

[1] Univ Cambridge, Addenbrookes Hosp, Sch Clin, Dept Med, Cambridge CB2 2QQ, England

[2] Austin & Repatriat Med Ctr, Dept Endocrinol, Heidelberg, Vic 3084, Australia

来源：

LANCET | 2006年 / 368卷 / 9540期

关键词：

D O I：

10.1016/S0140-6736(06)69394-X

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：973 / 974

页数：2

共 12 条

[1]

CANNER PL, 1980, NEW ENGL J MED, V303, P1038

[2] The impact of compliance with osteoporosis therapy on fracture rates in actual practice [J].

Caro, JJ ;

Ishak, KJ ;

Huybrechts, KF ;

Raggio, G ;

Naujoks, C .

OSTEOPOROSIS INTERNATIONAL, 2004, 15 (12) :1003-1008

[3] The impact of monitoring on adherence and persistence with antiresorptive treatment for postmenopausal osteoporosis: A randomized controlled [J].

Clowes, JA ;

Peel, NFA ;

Eastell, R .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (03) :1117-1123

[4] Treatment persistence with once-monthly ibandronate and patient support vs. once-weekly alendronate: results from the PERSIST study [J].

Cooper, A. ;

Drake, J. ;

Brankin, E. .

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2006, 60 (08) :896-905

[5] Compliance and persistence with bisphosphonate dosing regimens among women with postmenopausal osteoporosis [J].

Cramer, JA ;

Amonkar, MM ;

Hebborn, A ;

Altman, R .

CURRENT MEDICAL RESEARCH AND OPINION, 2005, 21 (09) :1453-1460

[6] Epidemiology and outcomes of osteoporotic fractures [J].

Cummings, SR ;

Melton, LJ .

LANCET, 2002, 359 (9319) :1761-1767

[7]

GUILERA M, 2005, OSTEOPOROSIS INT, V17, P1

[8] TREATMENT ADHERENCE AND RISK OF DEATH AFTER A MYOCARDIAL-INFARCTION [J].

HORWITZ, RI ;

VISCOLI, CM ;

BERKMAN, L ;

DONALDSON, RM ;

HORWITZ, SM ;

MURRAY, CJ ;

RANSOHOFF, DF ;

SINDELAR, J .

LANCET, 1990, 336 (8714) :542-545

[9] Assessment of compliance with osteoporosis treatment and its consequences in a managed care population [J].

Huybrechts, KF ;

Ishak, KJ ;

Caro, JJ .

BONE, 2006, 38 (06) :922-928

[10] Compliance with drug therapies for the treatment and prevention of osteoporosis [J].

McCombs, JS ;

Thiebaud, P ;

McLaughlin-Miley, C ;

Shi, JH .

MATURITAS, 2004, 48 (03) :271-287

← 1 2 →